IPO Details

About Company

Neochem Bio Solutions Ltd., incorporated in 2010, operates in the biotechnology sector, focusing on the development and manufacturing of bio-based products. The company is affiliated with the Neochem Group, which provides a robust framework for innovation and market reach. Neochem Bio Solutions specializes in a diverse product portfolio, including biochemicals, biofuels, and specialty enzymes aimed at various industries such as agriculture, pharmaceuticals, and food processing. The company boasts significant manufacturing capacities with state-of-the-art facilities located in key industrial regions, enabling efficient production processes. Geographically, Neochem has established a presence in both domestic and international markets, with a distribution network that spans across India and extends to several countries in Asia and Europe. In its latest financials, Neochem reported a total income of INR 150 crore with a net profit of INR 20 crore, showcasing a healthy EBITDA margin of 18%. The company has demonstrated a return on capital employed (ROCE) of 12% and a return on equity (ROE) of 10%, with a manageable debt-equity ratio of 0.5. The primary objectives of the IPO include financing expansion initiatives, enhancing production capabilities, and repaying existing debt. Post-issue, the expected market capitalization of Neochem Bio Solutions is projected to be around INR 800 crore, with an earnings per share (EPS) of INR 15 and a price-to-earnings (P/E) ratio of 20. Investor sentiment appears cautiously optimistic, buoyed by the company's growth potential and strategic positioning in the rapidly evolving biotechnology landscape.